Liu Xiaojing, Niu Na, Li Pibao, Zhai Liping, Xiao Ke, Chen Wendan, Zhuang Xuewei
Department of Clinical Laboratory Medicine, Shandong University Qilu Hospital, Jinan, 250012, China.
Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
Cancer Cell Int. 2021 Aug 13;21(1):425. doi: 10.1186/s12935-021-02115-3.
Long noncoding RNAs (lncRNAs) OGFRP1 is up-regulated in endometrial cancer and cervical carcinoma, and OGFRP1 suppression inhibits the malignant behavior of cancer cells. Here, we evaluated the expression pattern, biological function and potential mechanism of OGFRP1 in non-small cell lung cancer (NSCLC).
The expression of target genes in 25 pairs of clinically collected NSCLC and normal lung tissue samples was detected by qRT-PCR or western blot. We screened the siRNA (siOGFRP1) to down-regulate the expression of OGFRP1 in A549 and H1299 cells. The biological function of A549 and H1299 cells were examined by CCK8, wound healing and transwell assays. The molecular mechanism of OGFRP1 was further explored.
The expression of OGFRP1 in NSCLC tissues were higher than that in normal lung tissue. siOGFRP1 inhibited the proliferation, migration and invasion of A549 and H1299 cells. In addition, the expression of EMT-related and apoptosis-related proteins was changed by siOGFRP1 transfection. OGFRP1 can directly interact with miR-4640-5p, and siOGFRP1 increased the level of miR-4640-5p. Moreover, miR-4640-5p could directly bind to the 3' UTR region of eIF5A mRNA. eIF5A was highly expressed in NSCLC tissues, and predicted a poor prognosis. In addition, the expression of miR-4640-5p and eIF5A in NSCLC tissues were negatively correlated, while the expression of OGFRP1 and eIF5A were positively correlated. Knockdown of OGFRP1 inhibited the expression of eIF5A, while transfection of miR-4640-5p inhibitor up-regulated the expression of eIF5A.
Taken together, we demonstrated that down-regulation of OGFRP1 inhibited the progression of NSCLC through miR-4640-5p/eIF5A axis.
长链非编码RNA(lncRNA)OGFRP1在子宫内膜癌和宫颈癌中上调,OGFRP1抑制可抑制癌细胞的恶性行为。在此,我们评估了OGFRP1在非小细胞肺癌(NSCLC)中的表达模式、生物学功能及潜在机制。
通过qRT-PCR或蛋白质免疫印迹法检测25对临床收集的NSCLC组织和正常肺组织样本中靶基因的表达。我们筛选了小干扰RNA(siOGFRP1)以下调A549和H1299细胞中OGFRP1的表达。通过CCK8、伤口愈合和Transwell实验检测A549和H1299细胞的生物学功能。进一步探究OGFRP1的分子机制。
OGFRP1在NSCLC组织中的表达高于正常肺组织。siOGFRP1抑制A549和H1299细胞的增殖、迁移和侵袭。此外,siOGFRP1转染改变了上皮-间质转化(EMT)相关蛋白和凋亡相关蛋白的表达。OGFRP1可直接与miR-4640-5p相互作用,siOGFRP1增加了miR-4640-5p的水平。此外,miR-4640-5p可直接结合真核翻译起始因子5A(eIF5A)mRNA的3'非翻译区(UTR)。eIF5A在NSCLC组织中高表达,并预测预后不良。此外,NSCLC组织中miR-4640-5p和eIF5A的表达呈负相关,而OGFRP1和eIF5A的表达呈正相关。敲低OGFRP1可抑制eIF5A的表达,而转染miR-464-5p抑制剂可上调eIFIA的表达。
综上所述,我们证明下调OGFRP1通过miR-4640-5p/eIF5A轴抑制NSCLC的进展。